Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Share-based Compensation (2024 - 2025)

Cannabis Bioscience International Holdings' Share-based Compensation history spans 2 years, with the latest figure at $150000.0 for Q2 2025.

  • On a quarterly basis, Share-based Compensation rose 294.77% to $150000.0 in Q2 2025 year-over-year; TTM through Feb 2026 was $150000.0, a 38.89% increase, with the full-year FY2025 number at $220000.0, up 94.7% from a year prior.
  • Share-based Compensation hit $150000.0 in Q2 2025 for Cannabis Bioscience International Holdings, up from -$30000.0 in the prior quarter.
  • Over the last five years, Share-based Compensation for CBIH hit a ceiling of $150000.0 in Q2 2025 and a floor of -$30000.0 in Q4 2024.